| 51 |
25561870 | Modulation of CYP2D6 and CYP3A4 metabolic activities by Ferula asafetida resin. | 2014 Dec |
2 |
| 52 |
23064959 | Effect of abiraterone acetate plus prednisone on the pharmacokinetics of dextromethorphan and theophylline in patients with metastatic castration-resistant prostate cancer. | 2013 Jan |
2 |
| 53 |
23100173 | CYP2D6 phenotype indicative for optimized antiestrogen efficacy associates with outcome in early breast cancer patients. | 2013 Feb |
2 |
| 54 |
23340533 | Influence of CYP2D6 activity on pre-emptive analgesia by the N-methyl-D-aspartate antagonist dextromethorphan in a randomized controlled trial of acute pain. | 2013 Jan |
3 |
| 55 |
23355638 | A physiologically based pharmacokinetic model to predict disposition of CYP2D6 and CYP1A2 metabolized drugs in pregnant women. | 2013 Apr |
1 |
| 56 |
23665933 | CYP3A4 intron 6 C>T polymorphism (CYP3A4*22) is associated with reduced CYP3A4 protein level and function in human liver microsomes. | 2013 |
1 |
| 57 |
23835282 | Selective inhibition of the cytochrome P450 isoform by hyperoside and its potent inhibition of CYP2D6. | 2013 Sep |
3 |
| 58 |
23881421 | The effect of grape seed extract on the pharmacokinetics of dextromethorphan in healthy volunteers. | 2013 Nov |
2 |
| 59 |
24013574 | A clinical investigation of inhibitory effect of panobinostat on CYP2D6 substrate in patients with advanced cancer. | 2013 Oct |
2 |
| 60 |
21842479 | Aloe vera juice: IC₅₀ and dual mechanistic inhibition of CYP3A4 and CYP2D6. | 2012 Mar |
1 |
| 61 |
21976621 | Prediction of CYP2D6 drug interactions from in vitro data: evidence for substrate-dependent inhibition. | 2012 Jan |
3 |
| 62 |
22039821 | Pharmacophore, QSAR, and binding mode studies of substrates of human cytochrome P450 2D6 (CYP2D6) using molecular docking and virtual mutations and an application to chinese herbal medicine screening. | 2012 Jul |
1 |
| 63 |
22277677 | Inter-individual variability of in vivo CYP2D6 activity in different genotypes. | 2012 |
1 |
| 64 |
22305191 | Polysaccharide peptides from Coriolus versicolor competitively inhibit model cytochrome P450 enzyme probe substrates metabolism in human liver microsomes. | 2012 Mar 15 |
1 |
| 65 |
22422635 | Pharmacokinetic drug interactions between clobazam and drugs metabolized by cytochrome P450 isoenzymes. | 2012 Apr |
1 |
| 66 |
22451032 | Interleukin-6 and cytochrome-P450, reason for concern? | 2012 Sep |
1 |
| 67 |
22548589 | Serum dextromethorphan/dextrorphan metabolic ratio for CYP2D6 phenotyping in clinical practice. | 2012 Aug |
4 |
| 68 |
22553469 | The Discriminatory Value of CYP2D6 Genotyping in Predicting the Dextromethorphan/Dextrorphan Phenotype in Women with Breast Cancer. | 2012 Feb |
3 |
| 69 |
22762141 | Liver kidney microsomal type 1 antibodies reduce the CYP2D6 activity in patients with chronic hepatitis C virus infection. | 2012 Aug |
1 |
| 70 |
22777153 | Endoxifen levels and its association with CYP2D6 genotype and phenotype: evaluation of a southern Brazilian population under tamoxifen pharmacotherapy. | 2012 Aug |
2 |
| 71 |
21228393 | Myoclonus after dextromethorphan administration in peritoneal dialysis. | 2011 Jan |
3 |
| 72 |
21365364 | In vitro determination of the effect of Andrographis paniculata extracts and andrographolide on human hepatic cytochrome P450 activities. | 2011 Jul |
1 |
| 73 |
21447389 | Drug metabolism of CYP3A4, CYP2C9 and CYP2D6 substrates in pigs and humans. | 2011 Jun 14 |
1 |
| 74 |
21456632 | Sex differences in 3,4-methylenedioxymethamphetamine (MDMA; ecstasy)-induced cytochrome P450 2D6 inhibition in humans. | 2011 May |
1 |
| 75 |
21542294 | [CYP2D6*1, CYP2D6*10 co-expressed with CYPOR in Bac-to-Bac expression system and activity determination]. | 2011 Feb |
2 |
| 76 |
21542297 | [CYP2D6 genotypes and phenotypes in Chinese Han, Uygur and Kazakh populations]. | 2011 Feb |
1 |
| 77 |
21768449 | Dextromethorphan as a phenotyping test to predict endoxifen exposure in patients on tamoxifen treatment. | 2011 Aug 20 |
2 |
| 78 |
21803659 | Cytochrome P450 2D6 phenotyping in an elderly population with dementia and response to galantamine in dementia: a pilot study. | 2011 Aug |
2 |
| 79 |
21849623 | Immunochemical detection of cytochrome P450 enzymes in liver microsomes of 27 cynomolgus monkeys. | 2011 Nov |
2 |
| 80 |
22001938 | Heterologous expression of human cytochromes P450 2D6 and CYP3A4 in Escherichia coli and their functional characterization. | 2011 Dec |
1 |
| 81 |
24024018 | Metabolic capacity of CYP2D6 within an Iranian population (Mazandaran Province). | 2011 Spring |
2 |
| 82 |
20041473 | Effect of metabolic blockade on the psychoactive effects of dextromethorphan. | 2010 Jan |
4 |
| 83 |
20201775 | Effect of black seed on dextromethorphan O- and N-demethylation in human liver microsomes and healthy human subjects. | 2010 Jan |
3 |
| 84 |
20473659 | Discovery of the nonfunctional CYP2D6 31 allele in Spanish, Puerto Rican, and US Hispanic populations. | 2010 Sep |
3 |
| 85 |
20501912 | Cynomolgus monkey CYP2D44 newly identified in liver, metabolizes bufuralol, and dextromethorphan. | 2010 Sep |
3 |
| 86 |
20700584 | Limited effects of frequent CYP2D6*36-*10 tandem duplication allele on in vivo dextromethorphan metabolism in a Japanese population. | 2010 Oct |
3 |
| 87 |
20881950 | Assessment of activity levels for CYP2D6*1, CYP2D6*2, and CYP2D6*41 genes by population pharmacokinetics of dextromethorphan. | 2010 Nov |
3 |
| 88 |
20940534 | Effects of genetic variants of human P450 oxidoreductase on catalysis by CYP2D6 in vitro. | 2010 Nov |
2 |
| 89 |
21386204 | Single time point diagnostic breath tests: a review. | 2010 Mar |
1 |
| 90 |
18543297 | Metabolism of dextrorphan by CYP2D6 in different recombinantly expressed systems and its implications for the in vitro assessment of dextromethorphan metabolism. | 2009 Feb |
4 |
| 91 |
18591960 | The AmpliChip CYP450 test: cytochrome P450 2D6 genotype assessment and phenotype prediction. | 2009 Feb |
1 |
| 92 |
18838503 | Expression and functional analysis of CYP2D6.24, CYP2D6.26, CYP2D6.27, and CYP2D7 isozymes. | 2009 Jan |
4 |
| 93 |
19059219 | The mechanism causing the difference in kinetic properties between rat CYP2D4 and human CYP2D6 in the oxidation of dextromethorphan and bufuralol. | 2009 Mar 1 |
2 |
| 94 |
19133059 | Contribution of the activities of CYP3A, CYP2D6, CYP1A2 and other potential covariates to the disposition of methadone in patients undergoing methadone maintenance treatment. | 2009 Jan |
2 |
| 95 |
19158312 | Two novel CYP2D6*10 haplotypes as possible causes of a poor metabolic phenotype in Japanese. | 2009 Apr |
7 |
| 96 |
19356111 | O-demethylation of dextromethorphan using microbial cultures. | 2009 Jan |
2 |
| 97 |
19444798 | A validated SIM GC/MS method for the simultaneous determination of dextromethorphan and its metabolites dextrorphan, 3-methoxymorphinan and 3-hydroxymorphinan in biological matrices and its application to in vitro CYP2D6 and CYP3A4 inhibition study. | 2009 Nov |
3 |
| 98 |
19817501 | Polymorphism of human cytochrome P450 2D6 and its clinical significance: Part I. | 2009 |
1 |
| 99 |
17899220 | Active-site structure, binding and redox activity of the heme-thiolate enzyme CYP2D6 immobilized on coated Ag electrodes: a surface-enhanced resonance Raman scattering study. | 2008 Jan |
1 |
| 100 |
17971818 | The CYP2D6 activity score: translating genotype information into a qualitative measure of phenotype. | 2008 Feb |
1 |